Mike Watson is the Senior Director of Business Development for Nucleus Network, the largest Phase 1 Group in Australia with 2 sites and 150 beds. Nucleus Network provides First in Human clinical studies in numerous indications that includes vaccines. Mike is retired from the US Navy having served 20 years. He has been in the CRO Business Development space for 15 years with experience in pre-clinical Toxicology and Phase 1-4 clinical studies.